Research And Development
Sandwell and West Birmingham Hospitals NHS Trust has a strong culture of research and development. This is important because:
- Extensive research has shown that patients believe it is important for the NHS to carry out clinical research with the vast majority wanting to be treated in a hospital where research takes place
- It allows us develop and deliver more effective ways of looking after our patients
- Encouraging our clinical staff to ask questions, to develop research strategies to address them and to contribute to local, regional, national and international research studies will allow our healthcare workforce to reach its full potential. A culture of research in any NHS organisation empowers its staff to think critically and facilitates innovation
- It provides income generation through innovation to support the development of research capability and the translation of research findings into improvements in patient care
- The Government is committed to the promotion and conduct of research as a core NHS role, recognising that this is an integral component of its strategy to “improve the health and wealth of the nation”.
The Trust is proud of its long track record of excellence in clinical research. The following examples give a flavour of our ability to attract significant research grant funding, and to develop new products and approaches to clinical management that have improved the quality of life of many of our patients.
Research Management and Governance Manager, Zaida Khalil
0121 507 4092
Senior Research Nurse, Brian Gammon
0121 507 5129
Senior Research Midwife, Sarah Potter
0121 507 5129
Senior Research Nurse, Julie Colley
0121 507 3065
SWBH is a very research active Trust, hosting research in a breadth of specialities. If you are interested in conducting research at SWBH please get in touch with the R&D Department on email@example.com or call 0121 507 5439 and request to speak to a member of the RM&G Team. The R&D department support both experienced and new Chief Investigators and Principle Investigators, as well as Student Researchers.
Typically, SWBH NHS Trust is recruiting for more than 150 studies at any time. These will cover a variety of conditions and diseases. A list of the current studies that we are actively recruiting for is available on the ‘Active studies’ tab, here.
Any patients wishing to have an informal chat about taking part in research at the Trust can email firstname.lastname@example.org or telephone 0121 507 5439.
To find out more general information about clinical research and taking part in it, visit these useful websites:
National Institute for Health Research
NIHR Clinical Research Network – West Midlands
Please feel free to share your experiences of this service. Please e-mail your views to email@example.com
You can find out more about the research studies that are currently active within the Trust by clicking on the different areas below. Anyone wishing to enquire about participating in a study should email firstname.lastname@example.org or telephone 0121 507 5439, quoting the R&D reference number provided in the fourth column of the table.
Our Trust is committed to providing an open and transparent service for the patient population we serve. Along with the Governments Plan for Growth (published in March 2011) we are required to publish data related to our research activity. We will publish data on all Clinical Trials that have received NHS Permission since April 2014.
A clinical Trial is defined using the IRAS categories:
1) Clinical Trial of an investigational medicinal product
2) Clinical investigation or other study of a medical device
3) Combined trial of an investigational medicinal product and an investigational medical device
4) Other clinical trial to study a novel intervention or randomised clinical trial to compare interventions in clinical practice.
Data will be published under the following headings on a quarterly basis:
Performance in Initiating Research relates to whether the trial has recruited its first participant within the Department of Health (DoH) 70 day target (Date of valid research application to first patient recruited). This information is for any clinical trial regardless of whether it is commercial or non-commercial or whether it is adopted on to the NIHR portfolio or not. It will not always be possible to meet this target, if this is the case, the Trust provides formal reasons and explanations to the DoH.
- Performance of Initiating Clinical Research – Q1 (2017-18)
- Performance in Initiating Clinical Research Q2 2017-18
- Performanceof Initiating Clinical Research – Q1(b) (2017-18)
- Performance in Initiating Clinical Research – Q1(2016-17)
- Performance in Initiating Clinical Research – Q2(2016-17)
- Performance in Initiating Clinical Research – Q3(2016-17)
- Performance of Initiating Clinical Research – Q4 (2016-17)
- Performance in Initiating Clinical Research – Q1 (2015-16)
- Performance in Initiating Clinical Research – Q2 (2015-16)
- Performance in Initiating Clinical Research – Q3 (2015-16)
- Performance in Initiating Clinical Research – Q4 (2015-16)
Performance in Delivering Research relates to commercial trials that we have approved since April 1st 2014 and whether the trial has recruited its agreed recruitment target in the agreed time frame.
- Performance in Delivering Research – Q1 (2017-18)
- Performance in Delivering Research – Q1(a) (2017-18)
- Performance in Delivering Research – Q2 (2017-18
- Performance in Delivering Research – Q1(2016-17)
- Performance in Delivering Research – Q2(2016-17)
- Performance in Delivering Research – Q3(2016-17)
- Performance in Delivering Research – Q4 (2016-17)
- Performance in Delivering Research – Q1 (2015-16)
- Performance in Delivering Research – Q2 (2015-16)
- Performance in Delivering Research – Q3 (2015-16)
- Performance in Delivering Research – Q4 (2015-16)
- Performance in Delivering Research – Q4 (2014-15)